Vertex Pharmaceuticals IncKapitalflussrechnung
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 481.7 USD | 533,67 USD | 362,5 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 554,913 USD | 14 | 4 | 14 | 1 | 1 |
| #Shares | Short [%] | Short Ratio |
| 253.805.417 | 2,22 | 2,45 |
Kennzahl in 1000 USD | TTM 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 | 2001-12-31 | 2000-12-31 | 1999-12-31 | 1998-12-31 | 1997-12-31 | 1996-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 12.255.100 | 12.074.600 | 11.020.100 | 9.869.200 | 8.930.700 | 7.574.400 | 6.205.683 | 4.162.821 | 3.047.597 | 2.488.652 | 1.702.177 | 1.032.336 | 580.415 | 1.211.975 | 1.527.042 | 1.410.626 | 143.370 | 102.049 | 175.504 | 199.012 | 216.356 | 160.890 | 102.717 | 69.141 | 161.085 | 167.490 | 78.127 | 61.600 | 44.400 | 43.800 | 13.300 |
Cashflow aus operativer Geschäftstätigkeit | 4.240.600 | 3.631.400 | -492.600 | 3.537.300 | 4.129.900 | 2.643.500 | 3.253.505 | 1.569.330 | 1.270.286 | 844.942 | 236.103 | -365.432 | -513.199 | -51.570 | 267.841 | 143.735 | -635.442 | -427.586 | -226.482 | -252.476 | -22.475 | -172.054 | -142.160 | -167.623 | -79.539 | -8.074 | -16.644 | -31.800 | -31.100 | -9.400 | -40.300 |
▸ Operative Cashflow Marge | 34,6% | 30,07% | -4,47% | 35,84% | 46,24% | 34,9% | 52,43% | 37,7% | 41,68% | 33,95% | 13,87% | -35,4% | -88,42% | -4,26% | 17,54% | 10,19% | -443,22% | -419% | -129,05% | -126,86% | -10,39% | -106,94% | -138,4% | -242,44% | -49,38% | -4,82% | -21,3% | -51,62% | -70,05% | -21,46% | -303,01% |
Investitionsausgaben (CapEx) | 530.300 | 437.600 | 297.700 | 258.400 | 204.700 | 235.000 | 259.800 | 75.451 | 95.524 | 259.421 | 56.563 | 45.302 | 51.201 | 51.393 | 71.140 | 94.595 | 38.054 | 23.496 | 32.180 | 32.415 | 32.417 | 16.959 | 12.495 | 17.351 | 41.219 | 53.899 | 11.913 | 16.200 | 7.900 | 6.000 | 4.000 |
Cashflow aus Investitionstätigkeit | -1.321.500 | -945.400 | -3.770.000 | -3.141.700 | -321.100 | -340.900 | 99.388 | -1.235.318 | -202.158 | -437.681 | 104.469 | 268.856 | 73.959 | -54.130 | -425.817 | 212.412 | 7.301 | -508.732 | -360.650 | 405.166 | -208.471 | -1.732 | 107.428 | 119.585 | -15.962 | -145.087 | -236.329 | 36.400 | -20.400 | -118.800 | -40.400 |
Cashflow aus Finanzierungstätigkeit | -2.119.700 | -2.261.300 | -1.494.900 | -562.200 | -67.700 | -1.478.000 | -505.281 | 126.773 | -71.219 | 68.404 | 133.271 | 188.919 | 497.376 | 180.884 | 172.204 | -124.238 | 425.057 | 999.006 | 620.738 | -10.190 | 365.865 | 197.456 | -8.626 | 37.468 | 13.842 | -3.982 | 544.031 | 2.800 | 4.200 | 164.800 | 87.100 |
Freier Cashflow | 3.710.300 | 3.193.800 | -790.300 | 3.278.900 | 3.925.200 | 2.408.500 | 2.993.705 | 1.493.879 | 1.174.762 | 585.521 | 179.540 | -410.734 | -564.400 | -102.963 | 196.701 | 49.140 | -673.496 | -451.082 | -258.662 | -284.891 | -54.892 | -189.013 | -154.655 | -184.974 | -120.758 | -61.973 | -28.557 | -48.000 | -39.000 | -15.400 | -44.300 |
▸ Freie Cashflow Marge | 30,28% | 26,45% | -7,17% | 33,22% | 43,95% | 31,8% | 48,24% | 35,89% | 38,55% | 23,53% | 10,55% | -39,79% | -97,24% | -8,5% | 12,88% | 3,48% | -469,76% | -442,02% | -147,38% | -143,15% | -25,37% | -117,48% | -150,56% | -267,53% | -74,97% | -37% | -36,55% | -77,92% | -87,84% | -35,16% | -333,08% |
Ausgeschüttete Dividenden | - | - | - | - | - | -102.000 | -264.946 | -10.046 | -20.840 | - | - | - | - | - | - | - | - | -290.557 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | -1.930.699,999 | -2.017.400 | -1.177.100 | -427.600 | -172.000 | -1.561.300 | -739.407 | -192.015 | -350.043 | 344.840 | 68.230 | 185.592 | 274.615 | 265.878 | 191.721 | 124.862 | 33.434 | 290.557 | - | - | - | - | - | - | - | - | - | - | - | - | - |